FDA Clears ABK Biomedical's Eye90 Microspheres for Hepatocellular Carcinoma Treatment | Knobbe Martens
ABK Biomedical successfully secured Breakthrough Device Designation from the FDA on December 5, 2023, for its Eye90 microspheres device, which is indicated for the treatment of...